Skip to main content

Advertisement

Log in

Can Raynaud’s phenomenon be defined as a subtype of primary Sjögren’s syndrome? Comments on “Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome”

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 04 January 2022

The Original Article was published on 29 April 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lin W, Xin Z, Ning X, Li Y, Ren X, Su Y, Liu M, Guo S, Yang L, Liu Y, Zhang F, Zhang W (2021) ClinRheumatol 40:4081–4087

    Google Scholar 

  2. Herrick A, Muir L (2014) Raynaud’s phenomenon (secondary). BMJ ClinEvid 2014:1125–1132

    Google Scholar 

  3. CutoloM SV, Furst DE, Khanna D, Herrick AL (2017) Points to consider-Raynaud’s phenomenon in systemic sclerosis. Rheumatology (Oxford) 56:v45–v48

    Article  CAS  Google Scholar 

  4. Fraenkel L, Zhang Y, Chaisson CE, Evans SR, Wilson PWF, Felson DT (1998) The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. AnnIntern Med 129:208–211

    CAS  Google Scholar 

  5. Wigley FM (2001) Raynaud’s phenomenon is linked to unopposed estrogen replacement therapy in postmenopausal women. ClinExpRheumatol 19:10–11

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yan Liang or Zaixing Yang.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, C., Liang, Y. & Yang, Z. Can Raynaud’s phenomenon be defined as a subtype of primary Sjögren’s syndrome? Comments on “Clinical features and risk factors of Raynaud’s phenomenon in primary Sjögren’s syndrome”. Clin Rheumatol 41, 1265–1266 (2022). https://doi.org/10.1007/s10067-021-06023-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-06023-9

Navigation